1. University of Texas MD Anderson Cancer Center, Houston, TX;
2. Princess Margaret Hospital, Toronto, ON;
3. Service des Maladies du Sang, EA3518 and Centre d'Investigations Cliniques, Hôpital Saint-Louis, Paris, France;
4. Nizam's Institute of Medical Sciences, Hyderabad, India;
5. Singapore General Hospital Duke-National University of Singapore Graduate Medical School, Singapore;
6. ChemGenex Pharmaceuticals, a wholly owned subsidiary of Cephalon Inc, Frazer, PA; and
7. Hematology Department 1G, Hospices Civils de Lyon, Lyon, France